AR and prostate carcinoma: Novel compounds did not show any AR modulation activity but demonstrated unexpected antiproliferative activity (in prostate cancer and cervix cancer cell lines), with GI50 values around 5 μM, selectively inhibiting the growth of fast proliferating cancer cells while sparing noncancerous ones.